journal article·2021Open access

An effective polymeric nanocarrier that allows for active targeting and selective drug delivery in cell coculture systems

Maria Victoria Cano-Cortes, Patricia Altea-Manzano, Jose Antonio Laz-Ruiz, Juan Diego Unciti-Broceta, Francisco Javier Lopez-Delgado, Jose Manuel Espejo-Roman, Juan Jose Diaz-Mochon, Rosario M. Sanchez-Martin

Nanoscale· Volume 13· Issue 6

Abstract

In this manuscript, we report the development of a versatile, robust, and stable targeting nanocarrier for active delivery. This nanocarrier is based on bifunctionalized polymeric nanoparticles conjugated to a monoclonal antibody that allows for active targeting of either (i) a fluorophore for tracking or (ii) a drug for monitoring specific cell responses. This nanodevice can efficiently discriminate between cells in coculture based on the expression levels of cell surface receptors. As a proof of concept, we have demonstrated efficient delivery using a broadly established cell surface receptor as the target, the epidermal growth factor receptor (EGFR), which is overexpressed in several types of cancers. Additionally, a second validation of this nanodevice was successfully carried out using another cell surface receptor as the target, the cluster of differentiation 147 (CD147). Our results suggest that this versatile nanocarrier can be expanded to other cell receptors and bioactive cargoes, offering remarkable discrimination efficiency between cells with different expression levels of a specific marker. This work supports the ability of nanoplatforms to boost and improve the progress towards personalized medicine.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

GENYO

Centre for Genomics and Oncological Research

Pfizer/University of Granada/Andalusian Regional Government

PTS Granada

18016 Granada

Nanogetic S.L. Avda de la Innovacion 1

18016 – Granada

Spain

Funding

Agencia Estatal de Investigación · Instituto de Salud Carlos III · Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía · Ministerio de Educación y Cultura · Secretaría de Estado de Investigación, Desarrollo e Innovación

References (42)

Show source-provided references
1. Shi · Sci. Rep. · 2018 · 8 · 555110.1038/s41598-018-23902-5 ↗
2. Yoo · Cancers · 2019 · 11 · 64010.3390/cancers11050640 ↗
3. Guo · Anal. Chem. · 2019 · 91 · 1334910.1021/acs.analchem.9b03779 ↗
4. Ahmad · J. Med. Chem. · 2019 · 62 · 1047510.1021/acs.jmedchem.9b00511 ↗
5. Rosenblum · Nat. Commun. · 2018 · 9 · 141010.1038/s41467-018-03705-y ↗
6. Large · Adv. Ther. · 2019 · 2 · 180009110.1002/adtp.201800091 ↗
7. Zenych · Biomaterials · 2020 · 258 · 12029710.1016/j.biomaterials.2020.120297 ↗
8. Zhang · Biomater. Sci. · 2020 · 8 · 225510.1039/D0BM00069H ↗
9. Xu · Biomaterials · 2020 · 255 · 12020910.1016/j.biomaterials.2020.120209 ↗
10. Yong · Nano Lett. · 2019 · 19 · 182710.1021/acs.nanolett.8b04916 ↗
11. Stefanick · Nanoscale · 2019 · 11 · 441410.1039/C8NR09431D ↗
12. Wang · Nanoscale Horiz. · 2020 · 5 · 62810.1039/C9NH00514E ↗
13. Zhao · Acta Pharm. Sin. B · 2020 · 10 · 158910.1016/j.apsb.2020.04.012 ↗
14. Liu · Mol. Pharm. · 2020 · 17 · 127610.1021/acs.molpharmaceut.9b01280 ↗
15. Colombo · Bioconjugate Chem. · 2018 · 29 · 381710.1021/acs.bioconjchem.8b00667 ↗
16. Jin · Nanoscale · 2017 · 9 · 1636510.1039/C7NR06898K ↗
17. Altea-Manzano · Nanomedicine · 2017 · 12 · 159110.2217/nnm-2017-0118 ↗
18. Valero · Bioconjugate Chem. · 2018 · 29 · 315410.1021/acs.bioconjchem.8b00481 ↗
19. Delgado-Gonzalez · ACS Omega · 2018 · 3 · 14410.1021/acsomega.7b01984 ↗
20. Alexander · Mol. Biosyst. · 2010 · 6 · 39910.1039/B914428E ↗
21. Pietrovito · Proteomics · 2015 · 15 · 3410.1002/pmic.201300423 ↗
22. Cano-Cortes · Nanomedicine · 2020 · 24 · 10212010.1016/j.nano.2019.102120 ↗
23. Gao · Nanoscale · 2016 · 8 · 1502710.1039/C6NR04439E ↗
24. Xin · Sci. Rep. · 2016 · 6 · 110.1038/s41598-016-0001-8 ↗
25. Chen · Cell. Mol. Immunol. · 202010.1038/s41423-019-0353-7 ↗
26. Park · BMC Med. Genomics · 2019 · 12 · 110.1186/s12920-018-0466-3 ↗
27. Yoon · Mol. Pharm. · 2017 · 14 · 155810.1021/acs.molpharmaceut.6b01083 ↗
28. Díaz-Mochón · Org. Lett. · 2004 · 6 · 112710.1021/ol049905y ↗
29. Cano-Cortes · Polymers · 2020 · 12 · 110.3390/polym12061265 ↗
30. Thielbeer · Macromol. Biosci. · 2013 · 13 · 68210.1002/mabi.201200455 ↗
31. Unciti-Broceta · Sci. Rep. · 2015 · 5 · 110.1038/srep10091 ↗
32. Capuani · Nat. Commun. · 2015 · 6 · 799910.1038/ncomms8999 ↗
33. Bruniaux · Int. J. Pharm. · 2019 · 569 · 11857210.1016/j.ijpharm.2019.118572 ↗
34. Kong · Nano Lett. · 2020 · 20 · 394310.1021/acs.nanolett.0c01098 ↗
35. Ji · PLoS One · 2017 · 12 · e017158210.1371/journal.pone.0171582 ↗
36. Canfarotta · Nano Lett. · 2018 · 18 · 464110.1021/acs.nanolett.7b03206 ↗
37. Moeglin · Cancers. · 2019 · 11 · 35510.3390/cancers11030355 ↗
38. Wang · Nanomedicine · 2018 · 14 · 194910.1016/j.nano.2017.09.012 ↗
39. Li · Cancer Immunol. Immunother. · 2020 · 69 · 53510.1007/s00262-019-02457-y ↗
40. Li · ACS Appl. Mater. Interfaces · 2018 · 10 · 4110710.1021/acsami.8b14972 ↗
41. Ahmad · J. Med. Chem. · 2019 · 62 · 1047510.1021/acs.jmedchem.9b00511 ↗
42. Unciti-Broceta · Sci. Rep. · 2015 · 5 · 1009110.1038/srep10091 ↗